Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Relmada Therapeutics Inc. buy BiotechBee

Relmada Therapeutics Inc.
Start price
€0.50
27.04.25 / 50%
Target price
€1.50
28.02.27
Performance (%)
-46.00%
End price
€0.27
30.04.25
Summary
This prediction ended on 30.04.25 with a price of €0.27. The BUY prediction by BiotechBee for Relmada Therapeutics Inc. performed very badly with a performance of -46.00%. BiotechBee has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Relmada Therapeutics Inc. - -
iShares Core DAX® 0.734% -0.964%
iShares Nasdaq 100 -2.686% -2.409%
iShares Nikkei 225® -2.261% -4.038%
iShares S&P 500 -1.346% -1.510%

According to BiotechBee what are the pros and cons of Relmada Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Relmada Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -46.00%
Target price 1.500
Change
Ends at 28.02.27

Buy mit Kursziel 1,5

BiotechBee 
0
Report Share
27.04.25
In the thread Trading Relmada Therapeutics Inc.
Prediction Buy
Perf. (%) -46.00%
Target price 1.500
Change
Ends at 28.02.27

Buy beendet

BiotechBee 
0
Report Share
30.04.25

Stopped prediction by BiotechBee for Relmada Therapeutics Inc.

buy
Relmada Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.46
03.09.23
€5.00
31.12.25
-2.31%
06.09.23

Could be very worthwhile Investment >20% year
BiotechBee 
03.09.23 50%
buy
Relmada Therapeutics Inc.

Start price
Target price
Perf. (%)
€30.00
07.09.22
€45.00
31.12.24
-79.00%
14.10.22

Could be very worthwhile Investment >20% year
BiotechBee 
07.09.22 60%